Global Epilepsy Treatment Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 6.50 Million |
 Market Size (Forecast Year) |
USD 2.43 Million |
 CAGR |
% |
| Major Markets Players |
|
Global Epilepsy Treatment Market Segmentation, By Condition (Epilepsy Drug Resistant/Intractable Epilepsy, Others), Drug (First-Generation, Second-Generation, Third-Generation), Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies), End Users (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers) – Industry Trends and Forecast to 2031
Epilepsy Treatment Market Analysis
According to the World Health Organization reported that in 2017, the total cost of healthcare per person worldwide was USD 1,064.741. The cost of healthcare per person worldwide increased from USD 864.313 in 2008 to USD 1,110.841 in 2018, with the United States as the top payer at USD 10, 623.85 per capita in 2018. Domestic general government healthcare spending in the United States increased from USD 3515.82 in 2008 to USD 5355.79 in 2018. These are a few of the elements that have contributed to market expansion in recent years.
Global Epilepsy Treatment Market Size
Global epilepsy treatment market size was valued at USD 6.50 billion in 2023 and is projected to reach USD 2.43 billion by 2031, with a CAGR of 6.20% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes |
Epilepsy Treatment Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Pfizer Inc. (U.S.), Novartis AG (Germany), Abbott (U.S.), Neurelis Inc. (U.S.), GSK plc (U.K.), Johnson & Johnson Services Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (U.S.), Sumitomo Dainippon Pharma Co. Ltd (Japan), Bausch Health Companies Inc. (Canada), Sanofi (France), Takeda Pharmaceutical Company Limited (Japan), UCB S.A. (China), Marinus Pharmaceuticals Inc. (U.S.), Eisai Co. Ltd (Japan), H. Lundbeck A/S (Denmark), Supernus Pharmaceuticals Inc (U.S.), DAIICHI SANKYO COMPANY LIMITED (Japan) |
|
Market Opportunities |
|
Epilepsy Treatment Market Definition
The term "epilepsy" describes a long-term neurological condition that results in frequent, unjustified seizures. A person with epilepsy frequently experiences seizures that have no known cause. The actual origins of these seizures are yet unknown, but they may be brought by some stressful event or a prior brain injury. The disorder often affects both adults and children, however the danger of infection is higher in the elderly population.
Epilepsy Treatment Market Dynamics
Drivers
- Rise in injuries
The key drivers driving the epilepsy treatment market are the rise in accidents and brain injuries and the high rates of post-traumatic epilepsy (PTE) and post-traumatic seizure (PTS) occurrence in patients with brain injuries. The expansion of the epilepsy treatment market is accelerated by the rise in government funding for improving and developing effective medications and treatments for seizures, as well as the rise in R&D activities to provide cutting-edge healthcare facilities.
- Technological advancements
The market for epilepsy treatments is also impacted by groups working together to provide physicians and the public with better treatment options and awareness training initiatives.
- Rise in the geriatric population
The ageing population, rising epilepsy rates, increased public awareness of treatment alternatives, and declining treatment costs all favor the market. The development of new medications and therapeutic options and the approval and introduction of new products provide lucrative opportunities to the players in the epilepsy treatment market during the forecast period of 2024 to 2031. market for treating epilepsy.
Opportunities
- Increase in the number of research and development activities
The initiatives by the government and advancement in drugs and treatments across the globe are escalating the growth of epilepsy treatment market.
Restraints/Challenges
On the other hand, lack of affordability and emergence of epilepsy therapeutic methods in the developing nations are factors expected to obstruct the epilepsy treatment market.
This epilepsy treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the epilepsy treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Epilepsy Treatment Market
The pandemic interfered with neurology activities such as medical training and research. Epileptic treatment facilities as well as epilepsy patients are socially impacted by COVID-19. Due to the possibility of SARS-CoV-2 transmission from patient to patient or from healthcare practitioner to patient, patients' access to healthcare facilities has been severely constrained. Furthermore, standby admissions in hospitals with COVID-19 inpatients or in locations with widespread COVID-19 illness have been severely restricted due to worries about patient-to-patient transmission.
Epilepsy Treatment Market Scope
The epilepsy treatment market is segmented on the basis of condition, drug, distribution channel and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Condition
- Epilepsy Drug Resistant/Intractable Epilepsy
- Others
Drug
- First-Generation
- Second-Generation
- Third-Generation
Distribution Channel
- Hospitals
- Clinics
- Retail Pharmacies
- Online Pharmacies
End Users
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
Epilepsy Treatment Market Regional Analysis
The epilepsy treatment market is analyzed and market size insights and trends are provided by country, condition, drug, distribution channel and end users as referenced above.
The countries covered in the epilepsy treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the epilepsy treatment market because of the favourable government initiatives with the purpose to enhance the healthcare system.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2024 to 2031 due to the rise in government funding and support to improve the treatment facilities especially in the emerging economies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Epilepsy Treatment Market Share
The epilepsy treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to epilepsy treatment market.
Epilepsy Treatment Market Leaders Operating in the Market Are:
- Pfizer Inc. (U.S.)
- Novartis AG (Germany)
- Abbott (U.S.)
- Neurelis Inc. (U.S.)
- GSK plc (U.K.)
- Johnson & Johnson Services Inc. (U.S.)
- Teva Pharmaceutical Industries Ltd. (U.S.)
- Sumitomo Dainippon Pharma Co. Ltd (Japan)
- Bausch Health Companies Inc. (Canada)
- Sanofi (France)
- Takeda Pharmaceutical Company Limited (Japan)
- UCB S.A. (China)
- Marinus Pharmaceuticals Inc. (U.S.)
- Eisai Co. Ltd (Japan)
- H. Lundbeck A/S (Denmark)
- Supernus Pharmaceuticals Inc (U.S.)
- DAIICHI SANKYO COMPANY LIMITED (Japan)
Latest Developments in Epilepsy Treatment Market
- In August 2021, in an agreement signed between Yuyu Pharma and Novartis Korea, Yuyu obtained the exclusive distribution rights for three prescription drugs, including Tegretol, a medication containing the drug carbamazepine used to treat diseases including epilepsy
- In February 2021, A leading provider of remote diagnostics and monitoring, BioTelemetry, Inc., was purchased by Koninklijke Philips N.V.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
